Axinn Retains Top Rankings in LMG Life Sciences 2025
October 3, 2025
Axinn is pleased to announce that LMG Life Sciences has once again recognized the firm and its attorneys among the industry’s leaders for 2025. Partners Matt Becker and Aziz Burgy were named Life Sciences Stars, highlighting their continued excellence and impact in the field. Associate Ricardo Camposanto also retained his Rising Star designation, affirming his status as one of the industry’s emerging leaders.
This year, LMG Life Sciences ranked Axinn in Tier 2 for Hatch-Waxman Patent Litigation (Generic), underscoring the firm’s strength and experience in handling complex pharmaceutical patent cases.
LMG Life Sciences is the only legal ranking directory dedicated to identifying the top firms and lawyers across the life sciences sector.
About Axinn
Incisive. Inclusive. Invested. Inquisitive. We’re Axinn. Focusing on antitrust, intellectual property, and litigation, we make it our mission to understand your business so we can anticipate every move. Acting with precision and conviction, we protect and accelerate your business growth, always thinking ahead.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
The Empty Chair in Antitrust Conspiracy Cases
Webinar
Antitrust
USC Gould/Analysis Group Global Competition Law Thought Leadership Conference
Speaking Engagement
Antitrust
17th ACI Summit on Biosimilars & Innovator Biologics
Speaking Engagement
Intellectual Property
GCR Live: Europe 2026
Speaking Engagement
Antitrust
20th Annual IBA Competition Mid-Year Conference
Speaking Engagement
Antitrust
Axinn Partners Named to Lawdragon 500 Leading Global Litigators 2026
News
Litigation & Trials
Turning Up the Heat: Federal Circuit Sets the Temperature for pH Measurements in Precedential Opinion
Axinn Viewpoints
Intellectual Property
Axinn Represents Tecomet in Closing of Merger with Orchid Orthopedic
Deals & Cases
Antitrust
Recent Benchmarking Suits Highlight DOJ Enforcement Risks
Byline Articles
Antitrust
“Old Crime, New Code” – DOJ Outlines its Views on When Software and AI Can Facilitate Collusion
Axinn Viewpoints
Antitrust